波士顿科学公司将收购Valencia Technologies，用于其获得FDA批准的eCoin设备，用于治疗膀胱过度活跃症。 Boston Scientific to acquire Valencia Technologies for its FDA-approved eCoin device treating overactive bladder.

波士顿科学组织已同意购买巴伦西亚科技公司(一家私营医疗技术公司), 加入经林业发展局批准的eCoin可植入装置, 用于治疗膀胱过大成人的急症尿失禁症。 Boston Scientific has agreed to acquire Valencia Technologies, a private medical tech company, to add its FDA-approved eCoin implantable device for treating urge urinary incontinence in adults with overactive bladder. 在脚踝附近植入的硬币大小装置使用提盘神经刺激,显示68%的病人在试验中至少减少了50%的失禁病例。 The coin-sized device, implanted near the ankle, uses tibial nerve stimulation and showed 68% of patients had at least a 50% reduction in incontinence episodes in trials. 这项采购预计将在2026年初结束,它扩大了波士顿科学公司的泌尿和骨盆保健服务,特别是在可植入的乳房神经刺激方面,这是一个不断扩大的治疗区。 The acquisition, expected to close in early 2026, expands Boston Scientific’s urology and pelvic health offerings, particularly in implantable tibial nerve stimulation, a growing treatment area. 财务条款没有披露,预计交易对调整后的收入影响最小,但在公认会计原则基础上具有效益。 Financial terms were not disclosed, and the deal is expected to have a minimal impact on adjusted earnings but be dilutive on a GAAP basis.